FIBROUS DYSPLASIA OF BONE
Clinical trials for FIBROUS DYSPLASIA OF BONE explained in plain language.
Never miss a new study
Get alerted when new FIBROUS DYSPLASIA OF BONE trials appear
Sign up with your email to follow new studies for FIBROUS DYSPLASIA OF BONE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to strengthen weakened bones
Disease control CompletedThis study tested a drug called burosumab in people with fibrous dysplasia, a condition that causes weak, deformed bones and often low phosphate levels. Twelve participants aged 1 and older gave themselves burosumab injections at home once or twice a month for 48 weeks. Researche…
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: PHASE2 • Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Disease control
Last updated Apr 02, 2026 05:41 UTC
-
New hope for stubborn bone pain when standard treatments fail
Disease control CompletedThis study tested whether the drug tocilizumab could reduce bone pain and damage in people with fibrous dysplasia, a rare bone disorder. It focused on 19 patients who continued to have significant pain despite receiving standard bisphosphonate therapy. Researchers compared tocili…
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: PHASE2 • Sponsor: Hospices Civils de Lyon • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Scientists hunt for genetic fingerprint of rare bone disease
Knowledge-focused CompletedThis study aimed to understand why fibrous dysplasia, a rare bone condition, varies so much in severity between patients. Researchers looked for tiny genetic markers in the blood and bone tissue of 24 adults with the disease. The goal was to identify markers linked to more severe…
Matched conditions: FIBROUS DYSPLASIA OF BONE
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC